Stand Group is a biotechnology startup founded in 2014. The company's slogan emphasizes their commitment to providing comprehensive testing and R&D services to foster health, economic, and social development on a national and global scale. Stand Group offers diversified testing and R&D services to national and global health, economic, and social development markets. The latest Series C investment on 27 July 2023 saw participation from prominent investors including HighLight Capital, GP Healthcare Capital, 青岛高新创业投资有限公司, and Yuanshan Fund.
No recent news or press coverage available for Stand Group.